Washington Examiner
Sign in Subscribe
News
Politics
Trump Administration
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
Trump Administration
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Newsletters
Sign In Home
News
Politics Business World Investigations Justice Supreme Court Crime Entertainment Washington Secrets
Policy 2026 Election
Opinion
Columnists Editorials Think Tanks Beltway Confidential Op-Eds Editorial Cartoons
In Focus Restoring America Magazine Watch
Sponsored
Special Sections Advertise
TWS Archive
Advertisement
Advertisement
Home › Tags › Posts tagged Robert King

Tag: Robert King

"They raised the prices, I believe, to get filthy rich at the expense of our constituents," said Rep. Elijah Cummings of Maryland, the top Democrat on the committee. (Graeme Jennings/Examiner) Healthcare

Cummings: EpiPen CEO raised prices to get ‘filthy rich’

Robert King · September 21, 2016 7:40 pm
U.N. Secretary General Ban Ki-moon said that the goal of the meeting is to get commitments from countries and other important stakeholders. (AP Photo/Jason DeCrow) Healthcare

UN leader: Superbugs a dire threat

Robert King · September 21, 2016 2:59 pm
Mylan CEO Heather Bresch in her opening statement will attempt to shift focus to access provided to allergy patients. (Andrew Harrer/Bloomberg) Healthcare

CEO not expected to offer more discounts for EpiPen

Robert King · September 21, 2016 4:01 am
The Senate Finance Committee wrote to the Obama administration on Tuesday to examine whether there is enough oversight of the Medicaid Drug Rebate Program, after concerns that Mylan allegedly manipulated the program to avoid having to pay a higher rebate. (Daniel Acker/Bloomberg) Healthcare

Senators seek probe of EpiPen rebates

Robert King · September 20, 2016 8:43 pm
Over the past nine years, Medicare spending on EpiPens has increased by 1,151 percent. (Daniel Acker/Bloomberg) Healthcare

Medicare spending on EpiPens rose past 1,000 percent

Robert King · September 20, 2016 8:08 pm
This illustration made available by the Centers for Disease Control and Prevention shows the Shigella bacteria. On Thursday, April 2, 2015, the CDC said a drug-resistant strain of a stomach bug made its way into the U.S. and spread, causing more than 200 illnesses since last May. Many cases were traced to people who had recently traveled to the Dominican Republic, India or other countries. (AP Photo/CDC) Healthcare

UN to hold rare, major meeting on superbug threat

Robert King · September 20, 2016 4:01 am
lorida Gov. Rick Scott announced Monday that it has been 45 days since the last Zika infection was found in the Wynwood neighborhood, the Associated Press reported. (AP Photo) Healthcare

Zika no longer spreading in Miami neighborhood

Robert King · September 19, 2016 3:00 pm
The FDA approved the Exondys 51 injection to treat patients with Duchenne muscular dystrophy, a condition that primarily affects boys and quickly reduces motor function. (AP Photo) Healthcare

After pressure, FDA approves drug for rare disease

Robert King · September 19, 2016 2:56 pm
Healthcare

White House pushes for opioid funding this week

Robert King · September 19, 2016 2:14 pm
A new analysis found 2016 Obamacare premiums for the silver plan were lower in 39 states and the District of Columbia than the average premium for employer-sponsored plans. (AP Photo) Healthcare

Report: Obamacare premiums cost less than employer plans

Robert King · September 19, 2016 7:00 am
About 21 percent of clinical trials for cancer are not completed because of low participation. (iStock Photo) Healthcare

White House wants patients to find life-saving drug trials

Robert King · September 16, 2016 3:15 pm
House Republicans called for a federal watchdog to examine the National Institutes of Health's role in a controversy surrounding grants for brain research. (AP Photo/Paul Sancya) Healthcare

House Republicans target NIH, not NFL, over brain research

Robert King · September 15, 2016 7:27 pm
Advertisement
300 x 250
Advertisement
  • ‹Previous page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 237
  • ›Next page
Page 130 of 237
Advertisement
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Latest Videos
  • Political Perspectives
  • Restoring America Show
  • The Debrief
  • Reporter’s Notebook
  • Games
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement